Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Den

Showing results (61-70 of 492) with videos related to

Pageof 50
Sort By:
Anticancer Research|July 1, 1993
Exclusion from mammographic screening of women genetically predisposed to breast cancer will probably eliminate mammographically induced breast cancerW den Otter, T E Merchant, D Beijerinck, et al.
International Journal of Food Microbiology|October 11, 2016
The effect of different matrices on the growth kinetics and heat resistance of Listeria monocytogenes and Lactobacillus plantarumD C Aryani, M H Zwietering, H M W den Besten
Biomaterials|August 1, 1991
Macroporous calcium phosphate ceramics for bone substitution: a tracer study on biodegradation with 45Ca tracerW den Hollander, P Patka, C P Klein, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|July 1, 1995
Reevaluation of the superiority of polyethylene glycol-modified interleukin-2 over regular recombinant interleukin-2M R Bernsen, H F Dullens, W Den Otter, et al.
Anticancer Research|July 1, 1993
The difference between benign and malignant tumours explained with the 4-mutation paradigm for carcinogenesisJ W Koten, J P Neijt, B A Zonnenberg, et al.
Journal of Experimental Therapeutics & Oncology|July 1, 1996
The success of locoregional, low-dose recombinant interleukin-2 therapy in tumor-bearing mice is dependent on the time of rIL-2 administrationL A Everse, M R Bernsen, H F Dullens, et al.
Journal of Immunological Methods|January 1, 1980
Demonstration of migration inhibitory factor (MIF) in a murine system using myelomonocytic leukemia cells (WEHI-3)M C Kersten, E Pels, R A De Weger, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1986
The role of host lymphocytes and host macrophages in antitumor reactions after injection of sensitized lymphocytes and tumor target cells into naive miceH F Dullens, W Vuist, M Van der Maas, et al.
Frontiers in Microbiology|September 28, 2016
Quantification of Growth of Campylobacter and Extended Spectrum β-Lactamase Producing Bacteria Sheds Light on Black Box of Enrichment ProceduresWilma C Hazeleger, Wilma F Jacobs-Reitsma, Heidy M W den Besten
Anticancer Research|March 1, 1990
Stochastic theory of oncogenesisD J Derkinderen, O J Boxma, J W Koten, et al.
Pageof 50

Showing results (61-70 of 492) with videos related to

Sort By:
Pageof 50
Anticancer Research|July 1, 1993
Exclusion from mammographic screening of women genetically predisposed to breast cancer will probably eliminate mammographically induced breast cancerW den Otter, T E Merchant, D Beijerinck, et al.
International Journal of Food Microbiology|October 11, 2016
The effect of different matrices on the growth kinetics and heat resistance of Listeria monocytogenes and Lactobacillus plantarumD C Aryani, M H Zwietering, H M W den Besten
Biomaterials|August 1, 1991
Macroporous calcium phosphate ceramics for bone substitution: a tracer study on biodegradation with 45Ca tracerW den Hollander, P Patka, C P Klein, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|July 1, 1995
Reevaluation of the superiority of polyethylene glycol-modified interleukin-2 over regular recombinant interleukin-2M R Bernsen, H F Dullens, W Den Otter, et al.
Anticancer Research|July 1, 1993
The difference between benign and malignant tumours explained with the 4-mutation paradigm for carcinogenesisJ W Koten, J P Neijt, B A Zonnenberg, et al.
Journal of Experimental Therapeutics & Oncology|July 1, 1996
The success of locoregional, low-dose recombinant interleukin-2 therapy in tumor-bearing mice is dependent on the time of rIL-2 administrationL A Everse, M R Bernsen, H F Dullens, et al.
Journal of Immunological Methods|January 1, 1980
Demonstration of migration inhibitory factor (MIF) in a murine system using myelomonocytic leukemia cells (WEHI-3)M C Kersten, E Pels, R A De Weger, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1986
The role of host lymphocytes and host macrophages in antitumor reactions after injection of sensitized lymphocytes and tumor target cells into naive miceH F Dullens, W Vuist, M Van der Maas, et al.
Frontiers in Microbiology|September 28, 2016
Quantification of Growth of Campylobacter and Extended Spectrum β-Lactamase Producing Bacteria Sheds Light on Black Box of Enrichment ProceduresWilma C Hazeleger, Wilma F Jacobs-Reitsma, Heidy M W den Besten
Anticancer Research|March 1, 1990
Stochastic theory of oncogenesisD J Derkinderen, O J Boxma, J W Koten, et al.
Pageof 50